General information

Full name                               
European Research Infrastructure on Highly Pathogenic Agents
Short nameERINHA
Legal statusAISBL
Operational statusimplementation phase: partial operable
Coordinating institutionInserm                                                                                            
Director General
tba in September 2017
RI member countries          
ObserverGR, HU
ContactDiana Stepanyan, diana.stepanyan-yerdamian [at];
Hervé Raoul herve.raoul [at]



National nodes

This sections provides an overview on the national subsidiaries of the RI.


NameContact, website
Inserm                          Contact: Hervé Raoul, herve.raoul [at]
INSAContact: Sofia Nuncio, sofia.nuncio [at]
FOHMContact: Andreas Brave,
              andreas.brave [at]



Description of the organisation

ERINHA is a pan-European Research distributed research infrastructure on ESFRI roadmap dedicated to the study of highly infectious emerging and re-emerging diseases classified as Risk Group 4 (RG4). It brings together European high containment and complementary research facilities and expertise required to perform cutting-edge research in shorter timeframes. ERINHA provides access to its state of art BSL-4 laboratories and complementary capacities and expertise to perform excellence orientated in-vitro and in-vivo research projects, trainings and advise. A wide range of capabilities and functions from high basic research laboratory capacities to NHP modeling research will be provided by ERINHA, as well as expertise of senior scientists and access to complementary functions (from BSL1 to BSL4, genomics, proteomics etc.).

ERINHA produces the ideal environment to facilitate coordination of research on risk group 4 (RG4) agents in Europe. The infrastructure will contribute to the enhancement of the European and global capacity, capability and emergency preparedness in the response to global outbreaks.

Service offer

A list of services offered by ERINHA will be provided soon.